These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


122 related items for PubMed ID: 10731530

  • 1. Hypothalamic-pituitary-adrenal axis sensitivity to opioids in women with polycystic ovary syndrome.
    Ciampelli M, Guido M, Cucinelli F, Cinque B, Barini A, Lanzone A.
    Fertil Steril; 2000 Apr; 73(4):712-7. PubMed ID: 10731530
    [Abstract] [Full Text] [Related]

  • 2. Influence of body mass on the hypothalamic-pituitary-adrenal-axis response to naloxone in patients with polycystic ovary syndrome.
    Guido M, Ciampelli M, Fulghesu AM, Pavone V, Barini A, de Marinis L, Cento R, Caruso A, Lanzone A.
    Fertil Steril; 1999 Mar; 71(3):462-7. PubMed ID: 10065783
    [Abstract] [Full Text] [Related]

  • 3. Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: effect of naloxone.
    Lanzone A, Guido M, Ciampelli M, Fulghesu AM, Pavone V, Proto C, Caruso A, Mancuso S.
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):73-7. PubMed ID: 8796141
    [Abstract] [Full Text] [Related]

  • 4. Somatostatin treatment reduces the exaggerated response of adrenocorticotropin hormone and cortisol to corticotropin-releasing hormone in polycystic ovary syndrome.
    Lanzone A, Fulghesu AM, Guido M, Cucinelli F, Caruso A, Mancuso S.
    Fertil Steril; 1997 Jan; 67(1):34-9. PubMed ID: 8986680
    [Abstract] [Full Text] [Related]

  • 5. Corticotropin-releasing hormone induces an exaggerated response of adrenocorticotropic hormone and cortisol in polycystic ovary syndrome.
    Lanzone A, Petraglia F, Fulghesu AM, Ciampelli M, Caruso A, Mancuso S.
    Fertil Steril; 1995 Jun; 63(6):1195-9. PubMed ID: 7750588
    [Abstract] [Full Text] [Related]

  • 6. Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man.
    Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV.
    J Clin Endocrinol Metab; 1993 Feb; 76(2):388-91. PubMed ID: 8381800
    [Abstract] [Full Text] [Related]

  • 7. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
    Azziz R, Black V, Hines GA, Fox LM, Boots LR.
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2317-23. PubMed ID: 9661602
    [Abstract] [Full Text] [Related]

  • 8. Confirmation that offspring from families with alcohol-dependent individuals have greater hypothalamic-pituitary-adrenal axis activation induced by naloxone compared with offspring without a family history of alcohol dependence.
    Wand G, McCaul ME, Gotjen D, Reynolds J, Lee S.
    Alcohol Clin Exp Res; 2001 Aug; 25(8):1134-9. PubMed ID: 11505044
    [Abstract] [Full Text] [Related]

  • 9. Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic ovary syndrome.
    Romualdi D, Giuliani M, Draisci G, Costantini B, Cristello F, Lanzone A, Guido M.
    Fertil Steril; 2007 Jul; 88(1):131-8. PubMed ID: 17336978
    [Abstract] [Full Text] [Related]

  • 10. Naloxone-induced activation of the hypothalamic-pituitary-adrenal axis in suspected central adrenal insufficiency.
    Blevins LS, Dobs AS, Wand GS.
    Am J Med Sci; 1994 Sep; 308(3):167-70. PubMed ID: 8074133
    [Abstract] [Full Text] [Related]

  • 11. Hypothalamic-pituitary-adrenal axis in abdominal obesity: effects of dexfenfluramine.
    Boushaki FZ, Rasio E, Serri O.
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):461-6. PubMed ID: 9196609
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the pituitary-adrenal axis in hyperandrogenic women with polycystic ovary syndrome.
    Luboshitzky R, Ishai A, Shen-Or Z, Herer P.
    Neuro Endocrinol Lett; 2003 Apr; 24(3-4):249-54. PubMed ID: 14523365
    [Abstract] [Full Text] [Related]

  • 13. Effect of the opioid blockade on the feeding-induced growth hormone response to growth hormone-releasing hormone in women with polycystic ovary syndrome.
    Guido M, Romualdi D, Mancini A, Lattanzi F, Villa P, Barini A, Lanzone A, De Marinis L.
    Fertil Steril; 2002 Nov; 78(5):994-1000. PubMed ID: 12413983
    [Abstract] [Full Text] [Related]

  • 14. Relationship between plasma adrenocorticotropin, hypothalamic opioid tone, and plasma leptin.
    Wand GS, Schumann H.
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2138-42. PubMed ID: 9626152
    [Abstract] [Full Text] [Related]

  • 15. Response of the pituitary-adrenal axis to hypoglycemic stress in women with the polycystic ovary syndrome.
    Gennarelli G, Holte J, Stridsberg M, Lundqvist U, Massobrio M, Bäckström T, Berne C.
    J Clin Endocrinol Metab; 1999 Jan; 84(1):76-81. PubMed ID: 9920065
    [Abstract] [Full Text] [Related]

  • 16. Androgen responses to adrenocorticotropic hormone infusion among individual women with polycystic ovary syndrome.
    Maas KH, Chuan S, Harrison E, Cook-Andersen H, Duleba AJ, Chang RJ.
    Fertil Steril; 2016 Oct; 106(5):1252-1257. PubMed ID: 27473350
    [Abstract] [Full Text] [Related]

  • 17. The stimulatory effect of canrenoate, a mineralocorticoid antagonist, on the activity of the hypothalamus-pituitary-adrenal axis is abolished by alprazolam, a benzodiazepine, in humans.
    Grottoli S, Giordano R, Maccagno B, Pellegrino M, Ghigo E, Arvat E.
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4616-20. PubMed ID: 12364444
    [Abstract] [Full Text] [Related]

  • 18. Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamic-pituitary-adrenal axis in humans.
    Berardelli R, Karamouzis I, Marinazzo E, Prats E, Picu A, Giordano R, Ghigo E, Arvat E.
    Eur J Endocrinol; 2010 Jun; 162(6):1067-74. PubMed ID: 20219855
    [Abstract] [Full Text] [Related]

  • 19. Classification of polycystic ovary syndrome into three types according to response to human corticotropin-releasing hormone.
    Kondoh Y, Uemura T, Ishikawa M, Yokoi N, Hirahara F.
    Fertil Steril; 1999 Jul; 72(1):15-20. PubMed ID: 10428142
    [Abstract] [Full Text] [Related]

  • 20. Recovery of the rat hypothalamic-pituitary-adrenal axis after discontinuation of prolonged treatment with the synthetic glucocorticoid agonist dexamethasone.
    Calogero AE, Kamilaris TC, Johnson EO, Tartaglia ME, Chrousos G.
    Endocrinology; 1990 Oct; 127(4):1574-9. PubMed ID: 2169393
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.